Balance Performance and Quality of Life in Parkinson's Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-80
SponsorPamukkale University
About this trial
This observational study aims to examine the relationship between performance-based balance test results and quality of life in individuals with Parkinson's disease. It also seeks to determine which balance test best explains quality of life in this population.
Balance and functional performance will be assessed using the Six Spot Step Test, 30-Second Chair Stand Test, Timed Up and Go Test, Four Square Step Test, Berg Balance Scale, and 3-Meter Backward Walk Test. Quality of life will be evaluated using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The findings may help clinicians select appropriate assessment methods and develop rehabilitation programs that address the factors associated with quality of life in individuals with Parkinson's disease.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Willing to participate in the study and providing written informed consent
Having a diagnosis of idiopathic Parkinson's disease
Being 20 years of age or older
Being classified as stage 1-3 according to the Modified Hoehn and Yahr Scale
Disqualifiers
Being a healthy individual matched for age and sex with a participant diagnosed with Parkinson's disease Willing to participate in the study and providing written informed consent Being 20 years of age or older
Trial population
The study population will consist of individuals diagnosed with idiopathic Parkinson's disease who are followed at the Neurology Department of Pamukkale University Hospital and age- and sex-matched healthy individuals recruited from the same geographical region in Denizli, Türkiye.
Trial design
Design model
Case-crossover
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
40 Participants
are grouped into 2 trial groupsGroup A: Parkinson's Disease Group
Group B: Healthy Control Group
Trial outcomes
Primary outcomes
1
Health-Related Quality of Life Assessed by the PDQ-39
Health-related quality of life in individuals with Parkinson's disease will be assessed using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The PDQ-39 Summary Index ranges from 0 to 100, with higher scores indicating poorer health-related quality of life.
Time frame
During the single assessment session (approximately 25 minutes)Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: